DK0974350T3 - Tranilast-holdigt præparat til ydre påføring og fremgangsmåde til fremstilling af dette - Google Patents
Tranilast-holdigt præparat til ydre påføring og fremgangsmåde til fremstilling af detteInfo
- Publication number
- DK0974350T3 DK0974350T3 DK97902588T DK97902588T DK0974350T3 DK 0974350 T3 DK0974350 T3 DK 0974350T3 DK 97902588 T DK97902588 T DK 97902588T DK 97902588 T DK97902588 T DK 97902588T DK 0974350 T3 DK0974350 T3 DK 0974350T3
- Authority
- DK
- Denmark
- Prior art keywords
- tranilast
- active ingredient
- aqueous base
- preparing
- containing composition
- Prior art date
Links
- NZHGWWWHIYHZNX-CSKARUKUSA-N tranilast Chemical compound C1=C(OC)C(OC)=CC=C1\C=C\C(=O)NC1=CC=CC=C1C(O)=O NZHGWWWHIYHZNX-CSKARUKUSA-N 0.000 title abstract 4
- 229960005342 tranilast Drugs 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 3
- 238000010521 absorption reaction Methods 0.000 abstract 2
- 239000002270 dispersing agent Substances 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4549396 | 1996-02-07 | ||
PCT/JP1997/000283 WO1997028793A1 (fr) | 1996-02-07 | 1997-02-06 | Preparation a usage externe comprenant du tranilast et processus de production de cette preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0974350T3 true DK0974350T3 (da) | 2002-11-25 |
Family
ID=12720933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97902588T DK0974350T3 (da) | 1996-02-07 | 1997-02-06 | Tranilast-holdigt præparat til ydre påføring og fremgangsmåde til fremstilling af dette |
Country Status (12)
Country | Link |
---|---|
US (1) | US6239177B1 (fr) |
EP (1) | EP0974350B1 (fr) |
JP (1) | JP4154621B2 (fr) |
KR (1) | KR100449939B1 (fr) |
CN (1) | CN1081030C (fr) |
AT (1) | ATE222759T1 (fr) |
DE (2) | DE974350T1 (fr) |
DK (1) | DK0974350T3 (fr) |
ES (1) | ES2151464T3 (fr) |
HK (1) | HK1018218A1 (fr) |
PT (1) | PT974350E (fr) |
WO (1) | WO1997028793A1 (fr) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997029744A1 (fr) * | 1996-02-15 | 1997-08-21 | Kissei Pharmaceutical Co., Ltd. | Inhibiteur de la neoformation de vaisseaux sanguins |
JP4865958B2 (ja) * | 2001-05-23 | 2012-02-01 | 株式会社トクホン | 鎮痛抗炎症局所作用型の貼付剤 |
EP1559426B1 (fr) * | 2002-11-05 | 2011-02-09 | Lead Chemical Co. Ltd. | Preparations d'absorption percutanee contenant du 3-methyl-1-phenyl-2-pyrazolin-5-one |
JP2004307364A (ja) * | 2003-04-03 | 2004-11-04 | Yuutoku Yakuhin Kogyo Kk | 経皮吸収貼付剤 |
EP1685837A4 (fr) * | 2003-11-12 | 2009-03-25 | Lead Chem Co Ltd | Agent protecteur cerebral du type administre par absorption percutanee |
US9066912B2 (en) * | 2003-11-17 | 2015-06-30 | Ethicon, Inc. | Drug-enhanced adhesion prevention |
US20050106230A1 (en) * | 2003-11-17 | 2005-05-19 | Young Janel E. | Drug-enhanced adhesion prevention |
US20050239892A1 (en) * | 2003-11-21 | 2005-10-27 | Trustees Of Tufts College | Therapeutic avenathramide compounds |
US7105263B2 (en) * | 2003-12-30 | 2006-09-12 | Samsung Electronics Company | Dry toner comprising encapsulated pigment, methods and uses |
JP4590224B2 (ja) * | 2004-07-20 | 2010-12-01 | 株式会社日本点眼薬研究所 | トラニラストまたは薬理学的に許容される塩を含有する懸濁性医薬組成物 |
US7592371B2 (en) * | 2004-08-18 | 2009-09-22 | Medrx Co., Ltd. | External preparation |
US7473738B2 (en) * | 2004-09-30 | 2009-01-06 | Johnson & Johnson Vision Care, Inc. | Lactam polymer derivatives |
EP1824469A4 (fr) * | 2004-11-17 | 2008-07-30 | Nuon Therapeutics Pty Ltd | Procédé de modulation du fonctionnement des cellules b |
US20080009519A1 (en) * | 2004-11-17 | 2008-01-10 | Lawrence Steinman | Method of modulating t cell functioning |
JP2007051089A (ja) * | 2005-08-18 | 2007-03-01 | Medorekkusu:Kk | 外用剤 |
JPWO2007046544A1 (ja) * | 2005-10-21 | 2009-04-30 | 株式会社 メドレックス | カルボキシル基を有する肥満細胞脱顆粒抑制剤と有機アミンとの塩を含有する外用剤 |
JP4959991B2 (ja) * | 2006-03-03 | 2012-06-27 | 株式会社日本点眼薬研究所 | トラニラストまたはその薬理学的に許容される塩を含有する懸濁性医薬組成物 |
EP2035369B1 (fr) | 2006-07-05 | 2014-06-25 | Fibrotech Therapeutics PTY LTD | Composés thérapeutiques |
CA2670590C (fr) * | 2006-12-01 | 2018-06-12 | Wake Forest University Health Sciences | Dispositifs medicaux incorporant des inhibiteurs de collagene |
EP2030617A1 (fr) * | 2007-08-17 | 2009-03-04 | Sygnis Bioscience GmbH & Co. KG | Utilisation de tranilast et dérivés correspondants pour la thérapie de conditions neurologiques |
CN101152164B (zh) * | 2007-09-14 | 2011-04-06 | 李世荣 | 含有抗肥大细胞类药物的抗瘢痕外用贴膜及其制备方法 |
CN101152163B (zh) * | 2007-09-14 | 2010-05-26 | 李世荣 | 含有激素类药物的抗瘢痕外用贴膜及其制备方法 |
WO2011047432A1 (fr) | 2009-10-22 | 2011-04-28 | Fibrotech Therapeutics Pty Ltd | Analogues à cycles condensés d'agents anti-fibrotiques |
WO2012176668A1 (fr) * | 2011-06-20 | 2012-12-27 | 久光製薬株式会社 | Cataplasme contenant de la lidocaïne |
JP6096021B2 (ja) * | 2013-03-22 | 2017-03-15 | ファイテン株式会社 | 顎関節症用外用剤 |
JP6558117B2 (ja) * | 2014-08-19 | 2019-08-14 | 大正製薬株式会社 | 皮膚用剤 |
MA41266A (fr) * | 2014-12-22 | 2017-10-31 | Hisamitsu Pharmaceutical Co | Cataplasme |
WO2016136556A1 (fr) | 2015-02-24 | 2016-09-01 | 久光製薬株式会社 | Cataplasme adhésif pour la peau |
CN104784101A (zh) * | 2015-03-05 | 2015-07-22 | 中国药科大学制药有限公司 | 一种曲尼司特凝胶和软膏剂的处方及制备方法 |
KR101691472B1 (ko) | 2015-07-06 | 2017-01-09 | 이광재 | 배낭에 탈착이 용이한 스틱 걸이 |
CA3033534A1 (fr) * | 2016-08-23 | 2018-03-01 | Neurim Pharmaceuticals Ltd. | Procede de traitement du prurit et/ou des demangeaisons. |
WO2018144620A1 (fr) | 2017-02-03 | 2018-08-09 | Shire Human Genetic Therapies, Inc. | Composés anti-fibrotiques |
CN108324724A (zh) * | 2018-04-10 | 2018-07-27 | 苏州芝宇生物科技有限公司 | 一种克立硼罗可溶性膜制剂的制法及其应用 |
WO2020166665A1 (fr) | 2019-02-14 | 2020-08-20 | 久光製薬株式会社 | Cataplasme |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5124317A (en) * | 1985-08-02 | 1992-06-23 | Farmitalia Carlo Erba S.P.A. | Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
JPS62169723A (ja) * | 1986-01-22 | 1987-07-25 | Teisan Seiyaku Kk | 徐放化製剤 |
JPS63238024A (ja) * | 1987-03-26 | 1988-10-04 | Towa Yakuhin Kk | 水難溶性薬物を含有する外用ゲル組成物 |
EP0303445A1 (fr) * | 1987-08-13 | 1989-02-15 | Walton S.A. | Pansement pour l'administration transdermique de clébopride |
US5719197A (en) * | 1988-03-04 | 1998-02-17 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5446070A (en) * | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
JPH01294620A (ja) * | 1988-05-19 | 1989-11-28 | Kissei Pharmaceut Co Ltd | 水溶液製剤およびその製造方法 |
JPH07116029B2 (ja) * | 1989-04-04 | 1995-12-13 | キッセイ薬品工業株式会社 | トラニラスト水溶液製剤 |
JPH0794378B2 (ja) * | 1989-08-18 | 1995-10-11 | 久光製薬株式会社 | エアゾール剤 |
JP3243564B2 (ja) * | 1990-08-20 | 2002-01-07 | リードケミカル株式会社 | 外用貼付剤 |
JPH05178763A (ja) * | 1991-02-19 | 1993-07-20 | Nippon Saafuakutanto Kogyo Kk | 難溶解性薬物溶解剤組成物 |
JPH05163222A (ja) * | 1991-12-18 | 1993-06-29 | Kissei Pharmaceut Co Ltd | コラーゲン過剰合成疾患治療剤 |
US5989586A (en) * | 1992-10-05 | 1999-11-23 | Cygnus, Inc. | Two-phase matrix for sustained release drug delivery device |
JPH06128153A (ja) * | 1992-10-16 | 1994-05-10 | Kissei Pharmaceut Co Ltd | トラニラスト軟膏組成物およびその製造方法 |
AU667161B2 (en) * | 1993-04-28 | 1996-03-07 | Daiichi Pharmaceutical Co., Ltd. | Butyrophenone transdermal compositions |
WO1994026309A1 (fr) * | 1993-05-19 | 1994-11-24 | Hisamitsu Pharmaceutical Co., Inc. | Agent de solubilisation et preparation externe le contenant |
EP0709099A3 (fr) * | 1994-09-28 | 1996-07-24 | Senju Pharma Co | Suspension aqueuse nasale comprenant cyclodextrine |
JPH08295624A (ja) * | 1995-04-26 | 1996-11-12 | Read Chem Kk | プラスター基剤、その製造方法、該基剤を使用した外用貼 付剤 |
FR2736048B1 (fr) * | 1995-06-27 | 1997-08-01 | Atochem Elf Sa | Synthese du difluoromethane |
CA2208332A1 (fr) * | 1996-06-20 | 1997-12-20 | Hisamitsu Pharmaceuticals Co., Inc. | Composition pour l'administration de medicaments par iontopherese |
-
1997
- 1997-02-06 AT AT97902588T patent/ATE222759T1/de not_active IP Right Cessation
- 1997-02-06 DE DE0974350T patent/DE974350T1/de active Pending
- 1997-02-06 JP JP52837697A patent/JP4154621B2/ja not_active Expired - Lifetime
- 1997-02-06 US US09/117,658 patent/US6239177B1/en not_active Expired - Lifetime
- 1997-02-06 EP EP97902588A patent/EP0974350B1/fr not_active Expired - Lifetime
- 1997-02-06 WO PCT/JP1997/000283 patent/WO1997028793A1/fr active IP Right Grant
- 1997-02-06 PT PT97902588T patent/PT974350E/pt unknown
- 1997-02-06 DK DK97902588T patent/DK0974350T3/da active
- 1997-02-06 KR KR10-1998-0705983A patent/KR100449939B1/ko not_active IP Right Cessation
- 1997-02-06 ES ES97902588T patent/ES2151464T3/es not_active Expired - Lifetime
- 1997-02-06 DE DE69715049T patent/DE69715049T2/de not_active Expired - Fee Related
- 1997-02-06 CN CN97192132A patent/CN1081030C/zh not_active Expired - Fee Related
-
1999
- 1999-07-29 HK HK99103272A patent/HK1018218A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE974350T1 (de) | 2001-01-25 |
CN1081030C (zh) | 2002-03-20 |
KR100449939B1 (ko) | 2004-11-20 |
WO1997028793A1 (fr) | 1997-08-14 |
DE69715049D1 (de) | 2002-10-02 |
DE69715049T2 (de) | 2003-04-03 |
JP4154621B2 (ja) | 2008-09-24 |
ES2151464T3 (es) | 2002-12-16 |
EP0974350A1 (fr) | 2000-01-26 |
ATE222759T1 (de) | 2002-09-15 |
EP0974350B1 (fr) | 2002-08-28 |
CN1210462A (zh) | 1999-03-10 |
PT974350E (pt) | 2002-12-31 |
ES2151464T1 (es) | 2001-01-01 |
HK1018218A1 (en) | 1999-12-17 |
EP0974350A4 (fr) | 2000-01-26 |
KR19990082254A (ko) | 1999-11-25 |
US6239177B1 (en) | 2001-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0974350T3 (da) | Tranilast-holdigt præparat til ydre påføring og fremgangsmåde til fremstilling af dette | |
DE60045153D1 (de) | Zubereitungen zur perkutanen absorption | |
BRPI0412975A (pt) | espuma penetrante para uso farmacêutico | |
FI962770A0 (fi) | Transdermaalinen laite, joka sisältää polyvinyylipyrrolidonia liukoisuutta parantavana aineena | |
DK1299108T3 (da) | Parasiticidt præparat samt fremgangsmåde til fremstilling af dette præparat | |
PT922453E (pt) | Preparacao do tipo de absorcao percutanea contendo tulobuterol | |
ES2085886T3 (es) | Composicion farmaceutica de liberacion contenida. | |
NO945103D0 (no) | Ribozym med en termodynamisk stabil lökke | |
DE59703711D1 (de) | Ophtalmische Zusammensetzung mit verlängerter Verweilzeit am Auge | |
HK1084588A1 (en) | Precutaneous absorption preparations containing 3-methyl-1-phenyl-2-pyrazolin-5-one | |
DK174931B1 (da) | Lægemiddel med langsom frigivelse af den aktive bestanddel | |
DK0697814T3 (da) | Hæld-på-formuleringer indeholdende polymert materiale glycoler og glycerider | |
DE69720269D1 (de) | Gelierungsstabiele polyhalogenphosphazenverbindungen | |
BR0009771A (pt) | Utilização de derivados de bisindóis indigóides capazes de penetrarem na membrana de células | |
GR1001511B (el) | Στεροειδείς συν?έσεις. | |
ES2186207T3 (es) | Metodo para preparacion de formulaciones farmaceuticas. | |
DK0818973T3 (da) | Bionedbrydelig indretning | |
HUP9802897A3 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
DE69828586D1 (de) | Azelastinhydrochlorid enthaltende zubereitung mit guter perkutaner absorptionsfähigkeit und verringerter hautreizbarkeit | |
ATE258446T1 (de) | Benzophenanthridinalkaloid-enthaltende pestizide | |
CA2244679A1 (fr) | Preparation contenant du tranilast pour application externe et methode de production de cette preparation | |
DE59101818D1 (de) | Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung. | |
HK1009400A1 (en) | Combination drug containing tramadol and a calcium channel antagonist | |
BR0014058A (pt) | Produto sólido, composição, solução aquosa de 4,4-dimetil-5a-colesta-8,14,24-triene-3(beta) -ol, e, dispositivo tendo uma concavidade | |
DK338583D0 (da) | Fremgangsmade og medikament til reduktion af vaevslaesioner et dyr |